Finance

Beta
Lists
500680:BOM
Pfizer Ltd
₹4,454.50
+0.78%
(+34.65) 1D
Jun 5, 12:52:07 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500680...
Open
₹4,469.55
High
₹4,474.55
Low
₹4,432.55
Mkt. cap
203.45B
Avg. vol.
20.37K
Volume
554.00
Dividend
1.68%
Quarterly dividend
₹18.75
Ex-dividend date
Jul 17, 2026
P/E ratio
28.21
52-wk high
₹5,987.65
52-wk low
₹4,412.80
EPS
₹157.92
Shares outstanding
45.75M
No. of employees
2K
Open
₹4,469.55
High
₹4,474.55
Low
₹4,432.55
Mkt. cap
203.45B
Avg. vol.
20.37K
Volume
554.00
Dividend
1.68%
Quarterly dividend
₹18.75
Ex-dividend date
Jul 17, 2026
P/E ratio
28.21
52-wk high
₹5,987.65
52-wk low
₹4,412.80
EPS
₹157.92
Shares outstanding
45.75M
No. of employees
2K
News stories
From sources across the web
About Pfizer Ltd
CEO-
Employees1.6K
Founded1950
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.03B
6.42B
6.45B
6.29B
Cost of goods sold
2.11B
2.28B
2.25B
2.20B
Cost of revenue
2.11B
2.28B
2.25B
2.20B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
958.20M
946.70M
1.00B
771.80M
Operating expense
1.96B
1.99B
2.06B
1.88B
Total operating expenses
4.07B
4.27B
4.31B
4.08B
Operating income
1.96B
2.16B
2.14B
2.21B
Other non operating income
671.70M
418.50M
382.10M
407.20M
EBT including unusual items
2.60B
2.55B
1.92B
2.69B
EBT excluding unusual items
2.60B
2.55B
2.50B
2.60B
Income tax expense
677.80M
663.50M
501.10M
690.00M
Effective tax rate
26.12%
25.98%
26.11%
25.67%
Other operating expenses
859.80M
897.90M
917.70M
957.40M
Net income
1.92B
1.89B
1.42B
2.00B
Net profit margin
31.80%
29.43%
21.99%
31.76%
Earnings per share
-
41.32
40.42
42.21
Interest and investment income
-
-
-
-
Interest expense
-32.50M
-21.30M
-19.90M
-21.10M
Net interest expenses
-32.50M
-21.30M
-19.90M
-21.10M
Depreciation and amortization charges
144.10M
142.80M
142.60M
147.80M
EBITDA
2.02B
2.30B
2.20B
2.36B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more